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The binding of tr i t iated ~-endorphin (3H-~-EP) to brain homogenates is described. This had been difficult to 
achieve due to the lack of  availability of  3H-~-EP and to technical difficulties associated with high non-specific 
binding of ~-EP. We now report  that  3H-~-EP binding is saturable, stereospecific, has high affinity and is inhibited 
by sodium. Its dissociation rate is ten-fold longer than that of  naloxone. Its regional distribution exhibits interest- 
ing differences from naloxone and enkephalin binding. ACTHt.24 appears to displace it more effectively than it 
displaces 3H-naloxone. The results are discussed in terms of  multiple transmitter systems and the multiple opiate 
receptor hypothesis.  
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1. Introduction 
While the endogenous opioid, ~-endorphin 
(~-EP) was first discovered in the pituitary (Li 
and Chung, 1976; Bradley et al., 1976), it is 
also present within an anatomically distinct 
neuronal system in mammalian brain. We and 
others (Watson et al., 1978; Bloom et al., 
1978) have shown to existence of ~-EP and its 
precursors in a well-defined hypothalamic cell 
group which projects to a number of limbic 
and midbrain structures. This system is inde- 
pendent of the pituitary ~-EP system, and is 
readily distinguished from enkephalin path- 
ways (Watson et al., 1978). Interestingly, the 
synthetic machinery characteristic of pitui- 
tary ~-EP -- including the 31K prescursor 
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described by Mains et al. (1977) -- appears to 
exist within the brain. This conclusion is 
based primarily on immunohistochemical evi- 
dence demonstrating ~-LPH, ACTH and a 
number ofothex 3iK fragments (Watson et al., 
1978) within these ~-EP-containing neurons. 
~-EP is known to exhibit opiate-like proper- 
ties both in vitro (Cox et al., 1976) and in 
vivo (Loh et al., 1976). However, in pharma- 
cological doses, it also produces effects which 
differ, in part, from those of morphine. These 
include the induction of limbic seizures and 
rigidity at subanalgesic doses (Bloom et al., 
1976). While 3H-enkephalin binding had been 
studied and characterized, we know little 
about the specific properties of ~-EP binding. 
3H-~:EP has not been commercially available 
to date, preventing direct studies of its recep- 
tor interactions. Yet, the unique anatomical 
and biosynthetic properties of the brain ~-EP 
system, and the distinct pharmacological pro- 
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perties of ~-EP warrant a closer examination 
of  its interaction with a brain receptor. 
Whether such a receptor would prove to be 
identical or in some way discernable from the 
classical 'opiate receptor '  (Martin et al., 1976) 
would shed light on the function of/3-EP and 
on the hypothesis of  multiple opiate recep- 
tors. In this paper, we describe 3H-/3-EP bind- 
ing to rat brain membranes, including a char- 
acterization of 'opiate properties', a mapping 
of regional distribution and interaction with 
ACTH --  another 31K product.  
solubilized and counted. The coating of filters 
with BSA/polylysine (5 ml of 0.01% polyly- 
sine/0.4% BSA) is critical for detecting satur- 
able binding. Without coating, over 50% of 
3H-~-EP binds non~pecifically to the filters. 
Both techniques yield similar results, although 
the ratio of displaceable saturable counts to 
the total counts is better with filtration 
(about 60--80% at 3 nM) than it is with cen- 
trifugation (30--50% at 3 nM). In both tech- 
niques, the standard error of the replicates is 
approximately 1%. 
2. Materials and methods 
Tritium-labelled /~h-EP was synthesized 
according to a previously described procedure 
(Houghten and Li, 1978), achieving a specific 
activity of 50 Ci/mmole. The binding assay is 
descibed in greater detail elsewhere (Hewlett, 
Akil, Barchas and Li, in preparation). Briefly, 
whole rat brains minus cerebella are homogen- 
ized in 12 vol of Tris HC1 (pH 7.8 at 25°C) 
and centrifuged at 35000 × g for 30 min. The 
pellet is then resuspended in buffer and 
allowed to incubate for 1 h at room tempera- 
ture. It is then recentrifuged and suspended in 
the same volume. 3H-~-EP (0.025 m l ) a t  vary- 
ing concentrations is incubated with 0.2 ml of 
this membrane preparation in the presence or 
absence of unlabeUed/3-EP (in 0.025 ml). To 
determine saturable and non-specific binding, 
a 2 pM concentration of unlabelled ~-EP is 
routinely used. Incubation is carried out  for 
2--3 hours at 0°C. Because of ~-EP's great 
propensity to adhere to surfaces, separation 
of bound from free aH-/3-EP is extremely criti- 
cal and technically difficult. Good separation 
is achieved in one of two ways: the first 
involves centrifugation in a Sorvall centrifuge 
swing bucket  rotor (HS4) at 7000 rpm for 20 
min. The supernatant is then aspirated, the 
pellet resuspended in standard buffer and 
transferred to a vial for liquid scintillation 
counting. The second separation procedure 
employs rapid fil tration and washing on pre- 
coated GF/B Whatman filters, which are then 
3. Results 
3.1. Characterization 
Fig. 1 shows a Scatchard plot of  3H-~-EP 
binding in whole brain. ~-EP was added in 
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Fig. 1. Scatchard analysis of ~-EP binding in whole 
brain at .05, .16, .25, 0.75, 1.6, 4, 6, 10, 18, and 38 
nM concentrations. Assay carried out at 0°C for 2.5 h 
-- separation by filtration. KDI = 1.02 nM, KD2 = 
16.73 nM. 
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TABLE 1 
Time course of ~-EP binding at 0°C. 
Time Specific DPM's Specific/ 
(min) bound total × 100 
1 853 ± 40 37% 
5 1095 ± 65 52% 
10 2030 ± 100 57% 
30 3784±  63 78% 
60 4240 ± 150 75% 
120 5084 ± 202 66% 
180 4681 ± 175 62% 
240 4841 ± 160 64% 
24 h 3966 ± 100 70% 
65 nM. The tissue was incubated at 0°C for 
150 min, and bound ~-EP was separated by 
filtration. Scatchard analysis demonstrates a 
curvilinear plot which can be resolved into 
two components ,  with two distinct affinities 
and capacities (KD, = 1.0 X 10 -9 M; KD: = 
16.7 × 10 -9 M). Similar results are obtained 
by centrifugation. Displacement curves with 
unlabelled ~-EP and binding with varying con- 
centrations of labelled material yield similar 
estimates of affinity and capacity of binding. 
The total binding capacity in whole brain is 
est imated at 6.8 pmoles/g of tissue in the 
illustrated experiment  (and has ranged 
between 6.8 and 13.7 pmoles/g in other  
experiments) -- significantly lower than what 
is routinely obtained with 3H-naloxone bind- 
ing in the same preparation. Whether this dis- 
crepancy is entirely due to breakdown or to a 
true difference in receptor  number  remains to 
be determined. 
In three separate studies, we examined the 
t ime course of  3H-~-EP binding (table 1). The 
labelled peptide was incubated in the presence 
or absence of 2 ~M unlabelled ~-EP for vari- 
ous time periods ranging from 1 min to 24 h. 
The results indicate that  at 0°C equilibrium is 
reached at 2 h and remains relatively constant  
for 24 h. The slight decline seen in some prep- 
arations at later time points is probably due 
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Fig.  2. D issoc ia t ion  rate o f  3H-na loxone  and 3H-~-EP 
under identical conditions. After equilibrium was 
achieved, dissociation was brought about by adding a 
thousand-fold concentration of  unlabeled ligand and 
filtering at various time points (h) thereafter 
(abscissa). The curve with filled circles represent the 
3H-~-EP results. The unmarked line represents 
3H-naloxone dissociation (an equal number of  points 
was studied with 3H-naloxone but those can only be 
visualized with a different scale, due to the big differ- 
ence in time course). Incubation at 0°C; ~-EP tl/2 = 90 
rain; naloxone t% = 8.5 rain. Ordinate: % control. 
the membrane preparation. The best ratio of 
specific/total DPM is, in fact, achieved at 30 
minutes, rather than at equilibrium. 
The rate of  dissociation of  3Ha6-EP from 
the binding site was estimated by displacing 
the labelled compound with a high concentra- 
tion of  unlabelled ~-EP (fig. 2). Samples con- 
raining 2 nM 3H-~-EP were allowed to incu- 
bate to equilibrium for 2 h, at which point  
estimates of  total and non~pecific binding 
were obtained. Unlabelled ~-EP at a thousand- 
fold higher concentrat ion (2 #M) were then 
added. The samples were filtered at several 
t ime points thereafter  (1 rain to 3 h), with 
appropriate controls. A plot of  log percent 
specific binding versus t ime yielded an esti- 
mate of  t l / 2  = 90.33 + 5 min, which is signifi- 
cantly longer than the t l / 2  for naloxone 
under identical conditions ( t l / 2  = 9 rain) 
(fig. 2). 
At higher temperatures,  3H-~-EP binding is 
decreased rather than enhanced,  also pointirtg 
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to enzymatic breakdown of the opioid. While 
equilibrium at 25°C is achieved more rapidly, 
the number of specific DPM's bound at 25°C 
is only 30% of specific binding at 0°C when 
the incubation is allowed to proceed for 2 h. 
No specific binding could be seen at 37°C 
with 2 h incubations. 
The effect of tissue concentration on spe- 
cific binding was examined in two separate 
studies. Brain homogenates were resuspended 
in 6, 12, 24 or 36 vol of buffer and tested in 
the binding assay. The results showed a linear 
relation between tissue concentration and spe- 
cific binding, such that  binding doubled as the 
tissue concentration was doubled. 
The opiate nature of this binding was inves- 
tigated in a number of studies. The ability of 
naloxone, levorphanol, dextrorphan, leucine 
enkephalin (Leu-E) and methionine enkepha- 
lin to displace 3 nM of 3H-~-EP was studied 
both in whole brain and in brain parts. In all 
cases, 1 pM of the opiate agonists or antago- 
nists produced between 90 and 100% dis- 
placement of saturable ~-EP binding. Dextror- 
phan, on the other hand, used at the same 
concentration, left this binding unaltered. 
These results suggest that  the majority of 
3H-~-EP is binding to the stereospecific opiate 
receptor. 
The relative potencies of ~-EP and Leu-E 
are quite different depending on whether they 
are competing against 3H-Leu-E or 3H-fl-EP. 
While ~-EP is 13-fold more potent  than Leu-E 
in displacing 3H-~-EP (~-EP ICs0 = 3.5 X 
10 -9 M; Leu-E ICs0 = 45 × 10 -9 M), it is half 
as potent  as Leu-E in displacing 3H-Leu E 
binding (~-EP ICs0 = 20.5 × 10 -9 M; Leu E 
IC = 9 × 10 -9 M). 
Another characteristic of opiate binding is 
the 'sodium effect ' .  As an opiate agonist, ~-EP 
binding would be expected to decrease in the 
presence of sodium (Pert and Snyder, 1974; 
Simon et  al., 1973, 1975). In fact, 100 mM 
NaC1 produces a total inhibition of  all specific 
binding of 4 n M  3H-~-EP. Ten mM NaC1 
resulted in 57% inhibition of binding. 
In order to study the regional distribution 
of  3H-~-EP binding, 18 rats were sacrified and 
TABLE 2 
Specific 3H-~-EP and 3H-naloxone binding across rat 
brain regions, in the same preparations (pmoles/g 
tissue). 
3H-~-EP 3H-Naloxone 
3.25 3 3 . 2 5  3 . 2 5  33.25 
nM nM nM nM 
Striatum 2.82 1 9 . 8 2  10 .33  60.62 
Cortex 1.50 8.50 8.03 37.04 
Hypothalamus 1.58 7.08 8.78 53.27 
Hippocampus/ 2 . 4 4  14.96 6.90 36.00 
septum 
Midbrain/ 1.30 4.22 9.77 61.93 
thalamus 
Medulla/pons 0.76 5.78 4.34 29.30 
Cerebellum . . . .  
Pituitary . . . .  
their brains dissected into the following 
regions: hypothalamus,  striatum, hippocam- 
pus/septal region, cortex, medulla-pons, mid- 
brain, thalamus, cerebellum and pituitary 
(Holman et al., 1976, see table 2). 3H-/~-Ep 
binding was studied at two concentrations, 
3.25 nM and 33 nM, in order to tap both the 
high and low affinity components of the bind- 
ing. 
Both concentrations yielded a roughly simi- 
lar profile across regions, with striatum exhib- 
TABLE 3 
Effect of ACTH1.24 (10 pM) on 3H-opiate ligands (3 
nM). 
3H-~-Ep 3H- 3H-Me t- 
Naloxone enkephalin 
Expt. 1 
Control DPM 5285 4846 
ACTH added 2383 3191 
% Control 45% 66% 
Expt. 2 
Control 3754 3599 
ACTH added 1881 2671 
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Fig. 3. Interaction of ACTHz.24 with 3H-opiate ligands. Panel 3a represents the dose-dependent inhibition of  opi- 
ate binding by ACTHI.:4. As can be seen, 3H-/3-EP binding is significantly more inhibited by ACTH1.24 than is 
3H-naloxone binding (P < 0.01). 3b. Scatchard plot analysis of 3H-~3-EP in the presence or absence of 1/~M 
ACTHI.24 , showing inhibition of  both high and low affinity components of 3H-~-EP by ACTH. The displaced 
counts at each concentration of  3H-~-EP (i.e. the difference between the two curves) is indicated by the dashed 
lines. Similar results are seen with 10 and 50/~M ACTHl.24. 3c. Parallel to 3h, showing ACTH displacement of 
3H-naloxone. Note that 50/IM ACTH is depicted here, although similar results are obtained with 1 and 10 #M 
ACTH. The graph shows little change in the low affinity component of  naloxone, and the difference curve 
(dashed lines) depicts that only high affinity naloxone binding is displaced by ACTHI.24. 
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iting the highest binding and cerebellum 
exhibiting little or no specific binding. The 
rank order o f  the regions is roughly similar to 
what we commonly see with binding of other 
opiates (cf. table 2, Pert and Snyder, 1973). 
However, there are also interesting differences 
-- such as the relatively high binding of ~-EP 
in hippocampus -- a result not  obtained with 
either 3H-naloxone or 3H-enkephalin. While 
the unique profile may be due to differential 
breakdown, our experiments suggest that  
under our conditions, breakdown of 3H-~-EP 
is minimized. 
3.2. A CTH interactions 
centration of labelled ligands was computed,  
and the data were transformed for Scatchard 
plot analysis. Fig. 3a demonstrates that  
throughout  the r ange  of labelled concentra- 
tions ACTH,.24 produced a dose dependent  
inhibition of both 3H-naloxone and 3H-~-EP. 
However, it consistently produced higher inhi- 
bition against 3H-/3-EP. Scatchard analyses of 
the results showed that  all concentration of 
ACTH,.24 inhibited both high and low affinity 
components  of  3H-~-EP binding (fig. 3b). 
However, ACTHI.24, even at concentrations 
up to 50 pM inhibited primarily the high 
affinity but not  the low affinity component  
of  3H-naloxone binding (fig. 3c). 
Since /3-EP is synthesized from a common 
precursor molecule containing the structure 
of ACTH1.39, ~-MSH and a number  of related 
peptides, and since Terenius et al. (1975) had 
demonstrated some interaction of ACTH- 
related peptides with the opiate receptor, we 
tested for possible interactions between 31K- 
related substances and 3H-~-EP. ~-MSH, 
/~-MSH, ACTH,9, and modified ACTH4.9 (Org 
2766), and DTTE were ineffective at inhibit- 
ing 3H-/~-EP binding at concentrations of up to 
10 pM. On the other hand, ACTH1.24 exhib- 
ited dose dependent  inhibition of 3H-~-EP. 
The ICs0 for ACTHI.24 is 12 pM, obviously 
significantly higher than ICs0's of  opiate pep- 
tides or alkaloids. 
Nonetheless, the interaction appeared 
unique to ACTHI.24. It was therefore of inter- 
est to determine whether ACTH would dis- 
place all opiate binding equally, or whether  it 
would display closer interaction with /3-EP. 
Table 3 shows that  ACTH:.24 appears to dis- 
place 3H-/~-EP somewhat more effectively than 
it did 3H-naloxone or 3H-Met-enkephalin. 
Therefore, we under took a more thorough 
comparison of ACTH1.24 effect  on aH-/3-EP 
and 3H-naloxone binding. Full concentration 
curves for 3H-~-EP and 3H-naloxone were car- 
ried out  under four conditions: in the absence 
of any ACTH~.24, or in the presence of 1 pM, 
10 /~M and 50 pM ACTH~.24. Inhibition by 
each concentration of ACTH,.24 at each con- 
4. Discussion 
Thus, 3H-~-EP exhibits high affinity satur- 
able binding to rat brain membranes. This 
binding bears striking similarities to the 
'opiate receptor '  in that  it is displaced stereo- 
specifically by opiate alkaloids and is sensitive 
to sodium. Interestingly, Hazum et al. (1979) 
have recently characterized the binding of 
iodinated [D-Ala2]~-EP to brain membranes. 
They have noted that  the binding of this pep- 
tide is not  inhibited by 100 mM sodium chlo- 
ride. The contrast  between the two findings 
appears to be due to the D-Ala substitution, 
since in our hand both 3H-/~-EP and '2sI-~-EP 
are highly sensitive to sodium (Akil and Lin, 
in preparation). This suggests that  the substi- 
tution of glycine by D-Alanine brings about 
changes in the way the ~-EP analogue inter- 
acts with the opiate receptor. 
The present results suggest that  the two 
classes of endogenous opioid ligands identi- 
fied to date -- the enkephalins and fl-EP -- are 
recognized by membrane macromolecules 
which share a common structural unit, leading 
to a great deal of  'cross reactivity'. It is possi- 
ble that  the specificity of the interactions 
between opiate receptors and endogenous opi- 
ates resides primarily in the anatomical circui- 
try,  or in post-synaptic events. Nonetheless, 
the notion of 'multiple opiate receptors'  is 
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given partial support by the findings that ~-EP 
and enkephalin exhibit very different relative 
potencies depending on whether they are 
competing against 3H-enkephalin or 3H-fl-EP. 
The differential regional distribution in the 
binding of 3H-fi-EP and 3H-naloxone also 
points to a partial separation of subclasses of 
opiate receptors. 
The finding that ACTH1.24 interacts at 
micromolar concentration with opiate recep- 
tors is consistent with the previous report of 
Terenius et al. (1975). The present is an 
extension showing that ACTHI.24 discrimi- 
nates between 3H-fi-EP and 3H-naloxone, 
inhibiting both high and low affinity binding 
components of the former and only the high 
affinity component of the latter. This is con- 
sistent with the notion that ACTH and ~-EP 
are more closely related, due to their common 
biosynthetic origin. However, the physiologi- 
cal significance of this interaction is difficult 
to ascertain, since high concentrations are 
required for the competition. 
~-EP appears to dissociate extremely slowly 
from its binding site, a finding which is con- 
gruent with its high potency and long time 
course upon in vivo administration. Such slow 
dissociation has important implications for 
considering its mode of action in the brain. 
Since classical neurotransmitters are thought 
to produce rapid and short-lived effects on 
the postsynaptic neurons, a longer-acting 
endogenous ligand could be construed as serv- 
ing significantly different neuromodulatory 
functions. 
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